EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nonviral CRISPR/Cas9 mutagenesis for streamlined generation of mouse lung cancer models

Irene Lara-Sáez iD, Ángeles Mencía iD, Enrique Recuero iD, Yinghao Li iD, Marta García, Marta Oteo, Marta I Gallego iD, Ana Belén Enguita, Diana de Prado-Verdún iD, Sigen A, Wenxin Wang iD, Ramón García-Escudero iD und 2 weitere

Proceedings of the National Academy of Sciences · 09.07.2024 · 121 (28)

DOI: 10.1073/pnas.2322917121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 03.07.2024. Verfasst von Irene Lara-Sáez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Charles Institute of Dermatology, School of Medicine, University College Dublin, Belfield, Dublin D04 V1W8, Ireland. Hauptthemen laut MEDLINE: Lung Neoplasms, CRISPR-Cas Systems, PTEN Phosphohydrolase, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundación Científica Asociación Española Contra el Cáncer (AECC), MEC | Instituto de Salud Carlos III (ISCIII), Science Foundation Ireland (SFI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Functional analysis in mouse models is necessary to establish the involvement of a set of genetic variations in tumor development. A modeling platform to facilitate and cost-effectively analyze the role of multiple genes in carcinogenesis would be valuable. Here, we present an innovative strategy for lung mutagenesis using CRISPR/Cas9 ribonucleoproteins delivered via cationic polymers. This approach allows the simultaneous inactivation of multiple genes. We validate the effectiveness of this system by targeting a group of tumor suppressor genes, specifically Rb1 , Rbl1 , Pten , and Trp53 , which were chosen for their potential to cause lung tumors, namely small cell lung carcinoma (SCLC). Tumors with histologic and transcriptomic features of human SCLC emerged after intratracheal administration of CRISPR/polymer nanoparticles. These tumors carried loss-of-function mutations in all four tumor suppressor genes at the targeted positions. These findings were reproduced in two different pure genetic backgrounds. We provide a proof of principle for simplified modeling of lung tumorigenesis to facilitate functional testing of potential cancer-related genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCRISPR-Cas SystemsPTEN PhosphohydrolaseTumor Suppressor Protein p53Small Cell Lung CarcinomaMutagenesisAnimalsMiceHumansDisease Models, AnimalRetinoblastoma-Like Protein p107Retinoblastoma ProteinGene Editing

Stichwörter der Autor:innen

CRISPR/Cas9 ribonucleoproteinSCLCin vivo gene editinglung cancer models

Substanzen

PTEN PhosphohydrolaseTumor Suppressor Protein p53Pten protein, mouseRbl1 protein, mouseTrp53 protein, mouseRetinoblastoma-Like Protein p107Retinoblastoma Protein

Autor:innen und Institutionen

  • Charles Institute of Dermatology, School of Medicine, University College Dublin, Belfield, Dublin D04 V1W8, Ireland.
  • Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid 28040, Spain.
  • CB06/07/0019 Unit, Centro de Investigación Biomédica en Red en Enfermedades Raras, Madrid 28029, Spain.
  • Regenerative Medicine and Tissue Bioengineering Group, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Madrid 28040, Spain.
  • Cellular and Molecular Genitourinary Oncology Group, Institute of Biomedical Research Hospital "12 de Octubre", Madrid 28041, Spain.
  • Department of Biomedical Engineering, Polytechnic School, Carlos III University, Leganés, Madrid 28911, Spain.

ORCID-Profile: Irene Lara-Sáez, Ángeles Mencía, Enrique Recuero, Yinghao Li, Marta I Gallego, Diana de Prado-Verdún, Wenxin Wang, Ramón García-Escudero, Rodolfo Murillas

Förderung

  • Fundación Científica Asociación Española Contra el Cáncer (AECC)
  • MEC | Instituto de Salud Carlos III (ISCIII)
  • Science Foundation Ireland (SFI)
  • China Scholarship Council (CSC)
  • Debra International (DEBRA)

Zitieren

APA

Lara-Sáez, I., Mencía, Á., Recuero, E., Li, Y., García, M., Oteo, M., Gallego, M. I., Enguita, A. B., de Prado-Verdún, D., A, S., Wang, W., García-Escudero, R., Murillas, R., & Santos, M. (2024). Nonviral CRISPR/Cas9 mutagenesis for streamlined generation of mouse lung cancer models. Proceedings of the National Academy of Sciences, 121(28). https://doi.org/10.1073/pnas.2322917121

Vancouver

Lara-Sáez I, Mencía Á, Recuero E, Li Y, García M, Oteo M, et al. Nonviral CRISPR/Cas9 mutagenesis for streamlined generation of mouse lung cancer models. Proceedings of the National Academy of Sciences. 2024;121(28). doi:10.1073/pnas.2322917121

BibTeX
@article{LaraSez2024,
  author = {Lara-Sáez, Irene and Mencía, Ángeles and Recuero, Enrique and Li, Yinghao and García, Marta and Oteo, Marta and Gallego, Marta I and Enguita, Ana Belén and de Prado-Verdún, Diana and A, Sigen and Wang, Wenxin and García-Escudero, Ramón and Murillas, Rodolfo and Santos, Mirentxu},
  title = {Nonviral CRISPR/Cas9 mutagenesis for streamlined generation of mouse lung cancer models},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {28},
  doi = {10.1073/pnas.2322917121}
}
Kostenlos starten →